Skip to main content
OWLT
NYSE Life Sciences

Owlet Swings to Q1 Net Loss of $3.3M Despite 6.4% Revenue Growth

feedReported by Wiseek News
Sentiment info
Negative
Importance info
8
Price
$5.24
Mkt Cap
$139.47M
52W Low
$3.99
52W High
$16.94
Market data snapshot near publication time

summarizeSummary

Owlet, Inc. reported its first-quarter 2026 results, revealing a significant swing to a net loss of $3.3 million, a notable deterioration from a net income of $3.0 million in Q1 2025. Despite this, the company achieved a 6.4% year-over-year revenue increase to $22.5 million and improved its gross margin to 54.5%. Adjusted EBITDA remained negative at $(1.5) million. Management highlighted positive subscription momentum and the launch of its OnCall pediatric telehealth service. While operational improvements in revenue and gross margin are positive, the substantial shift to a net loss indicates ongoing profitability challenges that will be a key focus for investors.

At the time of this announcement, OWLT was trading at $5.24 on NYSE in the Life Sciences sector, with a market capitalization of approximately $139.5M. The 52-week trading range was $3.99 to $16.94. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed OWLT - Latest Insights

OWLT
May 07, 2026, 4:37 PM EDT
Source: Wiseek News
Importance Score:
8
OWLT
May 07, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
OWLT
Apr 30, 2026, 4:42 PM EDT
Filing Type: 10-K/A
Importance Score:
8
OWLT
Apr 06, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
8
OWLT
Apr 06, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
OWLT
Mar 09, 2026, 4:34 PM EDT
Filing Type: 10-K
Importance Score:
7
OWLT
Mar 05, 2026, 4:30 PM EST
Source: Reuters
Importance Score:
8
OWLT
Mar 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
OWLT
Feb 05, 2026, 5:25 PM EST
Filing Type: 8-K
Importance Score:
8